Question 1

Who is Nur Nicholson?

Accepted Answer

Nur Nicholson serves as Executive at Apellis Pharmaceuticals, Inc. (APLS). They have executed 23 insider transactions totaling $2.2M over their tenure at the company.

Question 2

What is Nur Nicholson's role at Apellis Pharmaceuticals, Inc.?

Accepted Answer

Nur Nicholson holds the position of Executive at Apellis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.

Question 3

Is Nur Nicholson buying or selling APLS stock?

Accepted Answer

Nur Nicholson has shown a selling trading pattern, with $0 in total purchases and $2.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.

Question 4

What are Nur Nicholson's largest insider transactions?

Accepted Answer

The largest transaction by Nur Nicholson was on Sep 18, 2023, when they sold $490.6K worth of APLS shares. This transaction involved 10,631 shares at $46.15 per share.

Question 5

What is Nur Nicholson's trading accuracy?

Accepted Answer

Nur Nicholson has a Personal Accuracy Score of 65/100, which measures the historical performance of their insider transactions. This score is calculated based on the timing and performance of their trades relative to market movements.

Question 6

How many companies is Nur Nicholson associated with?

Accepted Answer

Nur Nicholson has filed Form 4 transactions for 1 different company. Their primary association is with Apellis Pharmaceuticals, Inc. (APLS), where they serve as Executive.

Question 7

How much APLS stock does Nur Nicholson own?

Accepted Answer

Nur Nicholson currently owns 116,338 shares of Apellis Pharmaceuticals, Inc. (APLS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.

Question 8

What is Nur Nicholson's equity in Apellis Pharmaceuticals, Inc.?

Accepted Answer

Nur Nicholson's equity position in Apellis Pharmaceuticals, Inc. consists of 116,338 shares valued at approximately $0. As Executive, they have executed 23 insider transactions, with $0 in purchases and $2.2M in sales.

Question 9

Where can I find Nur Nicholson's SEC Form 4 filings?

Accepted Answer

All of Nur Nicholson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nur Nicholson has 23 Form 4 filings on record as an insider at Apellis Pharmaceuticals, Inc..

Question 10

What is Nur Nicholson's net worth from APLS?

Accepted Answer

Based on their current APLS stock holdings, Nur Nicholson has equity worth approximately $0 in Apellis Pharmaceuticals, Inc.. This value is based on 116,338 shares at current market prices and does not represent their total net worth, which may include other assets and investments.

DATE	TICKER	VALUE	TYPE	SHARES	PRICE	10b5-1
Jan 28, 2026	APLS	$0	Award	45,220	$N/A	Discretionary
Jan 22, 2026	APLS	$168.1K	Sale	7,725

Nur Nicholson

Position Evolution

Equity Curve

Trading Analytics

Recent Transactions

Largest Transactions

Companies Associated

Nur Nicholson Trading Summary

How Much APLS Stock Does Nur Nicholson Own?

Is Nur Nicholson Buying or Selling APLS?

Nur Nicholson's Recent Stock Transactions

Frequently Asked Questions

Track Nur Nicholson's Trades